H. Kaesemann

[Monoclonal antibodies in the diagnosis and follow-up of ovarian cancer. CA 125 as a tumor marker. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].

R. Kreienberg, G. Crombach, H. Caffier, 1986, Klinische Wochenschrift.

Cancer Antigen CA 125 in Serum of Patients with Ovarian Cancer

H. Caffier, H. Kaesemann, 1985 .

Evaluation of SCC antigen as a tumor marker for cervical cancer: a cooperative study of the GTMG

R. Kreienberg, G. Crombach, H. Caffier, 1988 .

Evaluation of CA 125 as a prognostic and predictive factor in ovarian cancer

R. Kreienberg, G. Crombach, M. Kaufmann, 1988 .

[The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].

R. Kreienberg, G. Crombach, H. Caffier, 1989, Deutsche medizinische Wochenschrift.

[Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1].

S. Schön, A. Gassel, T. Müller, 1997, Zentralblatt für Gynäkologie.